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Gregory L. Moneta, MD, Abstracts Section EditorIntra-operative colon mucosal oxygen saturation during aortic surgery
Lee ES, Bass A, Arko FR, et al. J Surg Research 2006;136:19-24.
Conclusion: A measurement of colonic mucosal oxygen saturation
correlates with the stoppage and restoration of aortic flow during aortic
surgery.
Summary: Colon ischemia complicating aortic reconstruction has a
high mortality rate. The authors developed a method of measuring colonic
mucosal ischemia during aortic surgery that correlates with interoperative
events. A spectrophotometer probe is inserted into a patient’s rectum before
aortic reconstruction. The device allows continuous measurement of colonic
mucosal oxygen saturation (CMOS). It was tested in 25 patients undergoing
aortic reconstruction. Buccal mucosal oxygen saturation, mean arterial
pressure, heart rate, pulse oximetry, and arrest and restoration of flow in the
aorta were also recorded during each operative procedure.
An endovascular aneurysm repair (EVAR) was performed in 20 patients
and an open repair was performed in five patients. During EVAR, CMOS
decreased from a baseline of 56%  8% to 26%  17% during the period of
infrarenal aortic balloon occlusion (P .0001). During open repair, CMOS
also decreased from 56%  9% to 15%  19% during clamping of the
infrarenal aorta and iliac arteries (P .0001). With restoration of aortic flow
in both open procedures and EVAR, CMOS returned to baseline values
(56.5%  10%, P  .81 compared with baseline). The time for CMOS to
recover after restoration of aortic flow was 6.4  3.3 minutes.
Comment: The technique offers a potential method of monitoring
colonic perfusion intraoperatively. Obviously, a number of details still need
to be determined, such as what is the lowest level of colonic mucosal oxygen
saturation that will sustain colonic viability. In addition, the potential ability
of this technique to monitor for postoperative colonic ischemia seems like an
interesting line of inquiry.
Clinical syndromes and clinical outcome in patients with pulmonary
embolism: Findings from the RIETE Registry
Lobo JL, Zorrilla V, Aizpuru F, et al. Chest 2006;130:1817-22.
Conclusion: Patients with pulmonary embolism (PE) who suffer pul-
monary infarction as a manifestation of their PE have a better initial and
long-term prognosis than patients with a PE that presents as dyspnea or
circulatory collapse.
Summary: Information in this study was derived from the Registro
Informatizado de la EnfermedadTromboEmbolica (RIETE) Registry of
consecutive patients with acute venous thromboembolism (VTE). This is a
multi-center observational registry that gathers and analyses data of clinical
outcomes and treatment patterns in patients with symptomatic, objectively
confirmed, acute VTE (deep venous thrombosis or PE). The current study
focused on patients enrolled in the registry with PE who did not have
pre-existing cardiac or pulmonary disease. Patients were classified into three
clinical syndromes: pulmonary infarction, dyspnea, or circulatory collapse.
Each group was analyzed with respect to clinical characteristics, laboratory
findings, and 3-month outcomes.
There were 3391 patients (82% of the RIETE Registry) who presented
with acute, symptomatic, objectively confirmed PE and who did not have
chronic lung disease or heart failure. Of these patients, 1709 (50%) had pulmo-
nary infarction, 1083 (32%) had isolated dyspnea, and 599 (18%) presented
with circulatory collapsed. Of the entire group, 149 (4.4%) died during the first
15 days after presentation, and 2.5% of the patients with pulmonary infarction
died between day 16 and day 90. Of those with isolated dyspnea, 6.2% died
(odds ratio [OR], 2.6; 95% confidence interval [CI] 1.7 to 3.8) and 6.5% with
circulatory collapse died (OR 2.7, 95% CI, 1.7 4.2). Thirty-one patients had
recurrent PE. Fourteen of these patients had initially presented with pulmonary
infarction, and five died (36%). Ten of the patients had initially presented with
dyspnea and five died (50%). All seven patients with recurrent PE who initially
presented with circulatory collapse died of their second PE.
Comment: The data make sense. Patients with pulmonary infarction
usually present with pleuritic chest pain or hemoptysis reflecting peripheral
emboli. Those with dyspnea and circulatory collapse have more central and
larger emboli and thus have more extensive vascular occlusion. It is impor-
tant to note that, no matter the initial presentation, recurrent PE 90 days
is a highly fatal event.
Preoperative MDCT evaluation of the artery of Adamkiewicz and its
origin
Takase K, Akasaka J, Sawamura Y, et al. J Comput Assit Tomogr 2006;30:
716-22.
1086Conclusion: Multidetector computed tomography (MDCT) allows
identification of the entire length of the artery of Adamkiewicz and its origin
in patients with thoracoabdominal aneurysms.
Summary: The artery of Adamkiewicz supplies the lower one third of the
spinal cord and can arise from a posterior branch of an intercostal or lumbar
artery. Identification of the artery of Adamkiewicz can be crucial in planning
which, if any, intercostal vessels should be reimplanted or preserved during
thoracoabdominal aneurysm repair. Proper identification and preservation of
the artery of Adamkiewicz may reduce neurologic complications of thoracoab-
dominal aneurysm repair. This applies to both open and endovascular repair.
In this study, the authors evaluated the capability of an eight-slice
multidetector CT scanner with 1-mm columniation, along with a rapid
injection protocol, to evaluate the continuity of the artery of Adamk-
iewicz and its parent artery. Ten patients with thoracoabdominal vascular
disease underwent MDCT, and in nine patients, the artery of Adamk-
iewicz was clearly visualized. The entire length of the intercostal or
lumbar arteries leading to the artery of Adamkiewicz could be traced in
eight patients. Three patients had occlusion of the parent artery of the
artery of Adamkiewicz.
Comment: It makes sense that identification of a patent artery of
Adamkiewicz and its parent vessel may be important in planning thoracoab-
dominal aneurysm repair. This may allow targeted preservation or reattach-
ment of specific intercostal or lumbar vessels. It may also be equally impor-
tant to know which patients have occluded parent vessels to the artery of
Adamkiewicz. Perhaps in such cases, reattachment or preservation of inter-
costal lumbar vessels is not necessary in thoracoabdominal aneurysm repair.
Equally possible, however, is that reattachment of additional vessels to
preserve collateral flow will be required.
The pathogenesis of venous thromboembolism: Evidence for multiple
interrelated causes
Brouwer JL, Veeger NJ, Kluin-Nelemans HC, et al. Ann Intern Med
2006;145:807-15.
Conclusion:Multiple genetic and environmental risk factors are addi-
tive in contributing to the risk of venous thromboembolism (VTE).
Summary: The authors sought to assess the effects of multiple throm-
bophilic defects and risk factors with respect to the absolute risk for VTE.
This was a retrospective family cohort study conducted in a single university
hospital in the Netherlands. Study subjects were 468 relatives of 91 pro-
bands with symptomatic hereditary deficiencies of protein C, protein S, or
antithrombin. Relatives were tested for 10 thrombophilic defects in addition
to the index deficiency. They were also assessed for exogenous risk factors
such as immobilization, trauma, surgery, oral contraceptives, and pregnancy.
Annual incidence and relative risk for VTE were compared in subjects with
deficiencies of protein C, protein S, or antithrombin and in nondeficient
relatives.
The annual incidence of VTE per 100 patient years in relatives with 0,
1, 2, or more additional thrombophilic defects or deficiencies were 1.16
(95% confidence interval [CI], 0.6 to 2.3), 1.75 (95% CI, 1.17 to 2.53), and
2.64 (95% CI, 1.67 to 3.96). The relative risk in nondeficient relatives was
0.06 (95% CI, 0.002 to 0.33) per 100 patient years. Adjusted relative risks
were 16.3 (95% CI, 2.0 to 131.0), 50.3 (95% CI, 6.5 to 390), and 103 (95%
CI, 12.5 to 843). In proband relatives with deficiencies of protein C, protein
S, or antithrombin, 38% with no additional defects, 57% with one additional
defect, and 81% with two or more additional defects had VTE by the age of
65 years. In comparison, only 5% of nondeficient relatives had VTE at 65
years (P  .001). In relatives with deficiencies of protein S, protein C, or
antithrombin, and additional thrombophilic deficiencies or defects, exoge-
nous risk factors further increased the risk of VTE from 1.2% to 2.5% per year
(relative risk, 2.1; 95% CI, 1.1 to 4.2).
Comment: The basic message is simple. In individuals who already
have a thrombophilic defect (protein C, protein S, or antithrombin deficien-
cies in this study), the risk of VTE increases further with additional throm-
bophilic defects or environmental risk factors. This, of course, is not the first
time such an observation has beenmade. Themagnitude of increased risk for
relatives of probands with symptomatic protein C, protein S, or antithrom-
bin deficiency is, however, sufficiently great that one wonders if prophylactic
anticoagulation may be indicated in such patients.
Familial cervical artery dissections: Clinical, morphologic and genetic
studies
Martin JJ, Hausser I, Lyrer P, et al. Stroke 2006;37:2924-9.
